Pirlindole
As of the edition of 20 October 2026, Pirlindole is a small molecule: marketed; acts on MAOA.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed
- Kind
- Small molecule
- Brand name
- Implementor
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Tecnimede - Sociedade Técnico-Medicinal, Sa
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| MAOA | Amine oxidase [flavin-containing] A | P21397 |